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ABSTRACT: Phosphate-based glasses (PBGs) are bioactive and
fully degradable materials with tailorable degradation rates. PBGs
can be produced as porous microspheres through a single-step
process, using changes in their formulation and geometry to
produce varying pore sizes and interconnectivity for use in a
range of applications, including biomedical use. Calcium
phosphate PBGs have recently been proposed as orthobiologics,
based on their in vitro cytocompatibility and ion release proﬁle.
In this study, porous microspheres made of two PBG
formulations either containing TiO2 (P40Ti) or without (P40)
were implanted in vivo in a large animal model of bone defect.
The biocompatibility and osteogenic potential of these porous
materials were assessed 13 weeks postimplantation in sheep and
compared to empty defects and autologous bone grafts used as negative and positive controls. Histological analysis showed
marked diﬀerences between the two formulations, as lower trabeculae-like interconnection and higher fatty bone marrow
content were observed in the faster degrading P40-implanted defects, while the slower degrading P40Ti material promoted
dense interconnected tissue. Autologous bone marrow concentrate (BMC) was also incorporated within the P40 and P40Ti
microspheres in some defects; however, no signiﬁcant diﬀerences were observed in comparison to microspheres implanted
alone. Both formulations induced the formation of a collagen-enriched matrix, from 20 to 40% for P40 and P40Ti2.5 groups,
suggesting commitment toward the bone lineage. With the faster degrading P40 formulation, mineralization of the tissue matrix
was observed both with and without BMC. Some lymphocyte-like cells and foreign body multinucleated giant cells were
observed with P40Ti2.5, suggesting that this more durable formulation might be linked to an inﬂammatory response. In
conclusion, these ﬁrst in vivo results indicate that PBG microspheres could be useful candidates for bone repair and regenerative
medicine strategies and highlight the role of material degradation in the process of tissue formation and maturation.
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■ INTRODUCTION
Bone grafts, either autologous or allogenic, are currently the
gold-standard strategy for the repair of bone defects due to
either their intrinsic osteoconductive, osteoinductive, and/or
osteointegration capacity. However, the use of autologous
bone grafts (ABG) presents many limitations, including donor
site morbidity, limited access to large quantities, and
immunocompatibility and tolerability issues related to
allogenic grafts.1,2 The increasing clinical demand for an
alternative bone regeneration substitute has considerably
boosted the development of new materials, of either synthetic
or natural origin, preferably with osteoinductive and
biocompatible properties. Hydroxyapatite and β-tricalcium
phosphate are already used in the clinic, showing osteocon-
ductive properties; however, their slow degradation rate has
been highlighted as a limitation to regeneration.3 Bioactive
glasses have been developed as biomaterials, including silica-
based glasses known as Bioglass. While silica-based glasses are
slow degrading materials, phosphate-based glasses (PBGs)
have signiﬁcant potential as they are fully resorbable and
display tailorable degradation properties (ranging from days,
months to years), including formulation and geometry.4 The
basic constituents of PBGs include P2O5, Na2O, and CaO
mimicking the mineral part of the bone in composition, while
doping with diﬀerent oxides such as AgO, CuO, ZnO, MgO,
and SrO has been reported to produce specialized glasses for
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varying therapeutic applications, including the stimulation of
angiogenesis,5 new bone formation,6 and antimicrobial7 and
antiresorptive activities.8,9 The material degradation rate is a
critical factor to provide the support required for optimal new
tissue formation. An ideal bone repair material would degrade
at a similar rate as that required for the formation of new bone,
mimicking the creeping substitution process happening
physiologically during bone remodeling.10 The addition of
TiO2 has been widely used to stabilize the glass structure
against rapid degradation, resulting in decreased glass solubility
ultimately inﬂuencing the biological properties of the
materials.11−13 Phosphate-based glasses have also been
manufactured in various geometrical forms, including ﬁbers,
disks, irregular particles, and microspheres, which can also
inﬂuence their degradation rates depending on the surface
area.14 Material geometry can also inﬂuence the ﬁnal
biomedical application and selection of the optimal in vivo
implantation route. Where a predeﬁned macrostructure is not
required, a regular spherical shape oﬀers advantages in particle
ﬂow properties enabling injection via a minimally invasive
delivery route in vivo.15 More importantly, manufacturing PBG
microspheres with a highly porous conformation has recently
been described, providing a three-dimensional bone biomi-
metic environment capable of supporting cell colonization and
encouraging tissue inﬁltration.14
The hypothesis here was that by using biomimetic porous
microspheres with diﬀerent degradation rates it could be
possible to modulate the bone tissue regeneration response.
The present study investigated the potential of two porous
calcium phosphate microsphere formulations, with and without
TiO2 (P40Ti and P40, respectively), implanted in an ovine
bone defect model. The PBG microspheres were also
combined with autologous bone marrow concentrate (BMC)
to test whether this would potentiate the biological response of
the materials. The addition of autologous BMC has been
considered as a possible regenerative strategy for diﬀerent
applications, including bone healing, due to the expected
enrichment in diﬀerent types of progenitor cells with
regenerative potential,16,17 including mesenchymal precursors
known to have osteogenic potential and exert a strong
paracrine activity with regenerative eﬀect.18 The evaluation
of biocompatibility and tissue growth parameters in vivo
suggests that these materials could provide a promising
resource for bone repair strategies.
■ MATERIALS AND METHODS
The reagents used were purchased from Thermo Fisher Scientiﬁc
(U.K.) unless otherwise stated.
Porous Microsphere Manufacturing and Characterization.
Porous calcium phosphate glass microspheres (40P2O5·16CaO·
24MgO·(20 − x)NaO·xTiO2 (x = 0, 2.5 mol %)) were manufactured
using the following precursors NaH2PO4, CaHPO4, MgHPO4, P2O5,
and TiO2 (Sigma-Aldrich, U.K.) according to the manufacturing
process previously described in ref 14 (see Table 1 for glass
formulations). Brieﬂy, glass precursors were weighed and dried in a
100 mL volume Pt/5% Au crucible at 350 °C for 30 min in an air
furnace and then melted and held at 1150 °C for 90 min and at 1280
°C for 120 min in case of Ti-containing glass. The molten glasses were
then poured onto a steel plate and allowed to cool down to room
temperature. Afterward, cooled glasses were ground into micro-
particles using a Retsch PM100 milling machine and sieved into
varying sizes ranging from 63 to 125 μm. Porous glass microspheres
were then produced by mixing the glass powder with a calcium-based
porogen and processing the materials via ﬂame spheroidization
utilizing a thermal spray gun (Metallisarion, U.K.) using an oxy-
acetylene ratio of 3:3. Post manufacture, the porous microspheres
were washed by gently stirring in 5 M acetic acid for 2 min, followed
by deionized water for 5 min, and then dried in an oven at 50 °C for
24 h.14
Microsphere porosity was evaluated as described previously by
Hossain et al.14 using mercury intrusion porosimetry (Micromeritics
Autopore IV 9500), while the relative density was measured using a
helium gas pycnometer (Micromeritics AccuPyc 1330) in approx-
imately 1 g of microspheres of both formulations. For the
measurement of tapped density, approximately 1 g of microspheres
was transferred into a 10 mm graduated cylinder and tapped until the
sample volume became constant using a Quantachrome Autotap
machine. The tapped density was then calculated by dividing the mass
with the ﬁnal volume obtained. At least 10 measurements were
conducted to derive an average density value.19 The microsphere
degradation study was performed as previously described14 to
calculate the percentage of mass loss at days 1, 3, 7, 14, 21, and 28.
Preparation of Bone Marrow Concentrate and in Vivo Bone
Defect Model. Twenty skeletally mature English mule ewes (age 2−
4 years, weight 58.5−81 kg) were randomly assigned to six treatment
groups (Table 2). All procedures were carried out in accordance with
UK Home Oﬃce Regulations and protocols and were approved by
the University of Nottingham Animal Welfare and Ethical Review
Body (AWERB). Autologous bone marrow aspiration was carried out
under general anesthesia at the beginning of the surgical procedure as
described20 and returned within the defect, as indicated during the
same anesthetic event. Anesthetized animals were placed in lateral
recumbency and bone marrow aspirate was harvested from the
sternum using 8 gauge 100 mm Jamshidi needles (UK Medical Ltd.,
Sheﬃeld, U.K.) to collect aspirates in heparinized tubes. Three
insertions of the Jamshidi needle were performed collecting a
maximum total of 20 mL of bone marrow.20 Bone marrow
concentrate (BMC) samples were obtained by centrifugation of the
aspirates for 30 min at 200 g; pellets were then incubated with red
blood cell lysis buﬀer (Sigma-Aldrich) for 5 min at room temperature
to reduce the erythrocyte contaminants. Samples were washed with
phosphate-buﬀered saline and centrifugated at 200 g for 5 min. The
resulting pellets were ﬁnally resuspended in cell culture medium
(αMEM supplemented with 10% of fetal calf serum and L-glutamine)
in a ﬁnal volume of 800 μL.
Table 1. PBG Formulations Presented as mol % for the Two Formulations Used
compositional information
glass code P2O5 (mol %) CaO (mol %) Na2O (mol %) MgO (mol %) Ti (mol %)
P40 40 16 20 24 0
P40Ti2.5 40 16 17.5 24 2.5
Table 2. Treatment Groups Included in the Studya
animal group treatment received number of implants (n)
P40 P40 6
P40 + BMC P40 + BMC 6
P40Ti2.5 P40Ti2.5 6
P40Ti2.5 + BMC P40Ti2.5 + BMC 6
ABG autologous bone graft 8
empty empty defect 8
aBMC = bone marrow concentrate; ABG = autologous bone graft.
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A cylindrical bone defect of 8 mm width × 15 mm depth was
drilled into the cancellous bone of medial femoral condyles of both
the left and right hind legs (Suppl. Figure 1B).20,21 The drills used to
create the defects were cooled using sterile saline to ensure no heat
damage to the bone. Animals received P40 or P40Ti2.5 microspheres,
with or without BMC, according to following group pairing: P40/
P40Ti2.5 + BMC; P40Ti2.5/P40 + BMC (n = 6). For material
sterilization, microspheres were washed in EtOH 70%, dried
overnight in a vacuum oven at 50 °C, and ﬁnally irradiated through
Co-60 γ-irradiation (25−35 kGy radiation dose) (kindly provided by
Ceramisys Ltd., U.K.). For implantation, microspheres were gently
mixed with 800 μL of DMEM (with or without BMC) added
dropwise to produce a paste that was delivered to ﬁll the defect site
using a modiﬁed 2 mL syringe (Suppl. Figure 1A,B). After
implantation, the ﬁlled defect was tightly covered with any available
periosteum sown over the top and the release of the muscle lying over
the top of the femoral condyle covering the defect, further secured by
the closure of the soft tissue before suturing the skin. Defects left
empty or ﬁlled with autologous bone graft (ABG) were used as
negative and positive controls, respectively. Bone cores harvested
from the empty defects were broken into small pieces using a bone
rongeur and then implanted in the ABG group defects. Animals
received analgesia and antibiotics as required and were closely
monitored postoperatively for any clinical signs of pain. Throughout
the study, body weight and body condition scores were recorded for
all sheep. Body condition scores highlighted the health and amount of
fat on an animal, with a score of 1 indicating an emaciated animal and
a score of 5 indicating an obese animal, with a score of 3 classed as
healthy. Animals were sacriﬁced after 13 weeks by an intravenous
overdose of pentobarbital. The femoral condyles were collected and
ﬁxed in 10% neutral buﬀered formalin for a minimum of 7 days before
further processing.
Microcomputed Tomography Analysis. A high-resolution
micro-X-ray-computed tomography system (micro-CT, Skyscan
1174) was used to determine bone ingrowth within the defects in
the femoral condyles. Fixed samples were scanned at a voltage of 50
kV, a current of 800 μA, and a voxel resolution of 32 μm. PBG
microsphere samples were scanned at a voxel resolution of 9 μm. A
0.50 μm aluminum ﬁlter was also applied. A cylinder slightly larger
than the defect (9 mm width × 15 mm height) was used to calculate
total bone ﬁll to ensure that any variation in the defect size was
included, while an internal cylinder (6 mm width × 8 mm height) was
applied to measure core values and exclude callous tissue (Suppl.
Figure 3A). A threshold of 255/70 (threshold70) was selected to
segment fully mineralized bone and 255/50 (threshold50) was
selected to segment both mature and immature bones from
surrounding tissue. The immature bone values were obtained by
the following equation
immature bone threshold threshold50 70= −
Transmission images were reconstructed using Skyscan supplied
software (NRecon) with the resulting two-dimensional image
representing a single 32 μm slice (1/256).
Tissue Processing and Histological Analysis. Twenty-two
bone samples from all treatment groups (ﬁve samples for groups P40
and P40 + BMC, four samples for groups P40Ti2.5 and P40Ti2.5 +
BMC, two samples for empty and ABG) were dehydrated in
progressively higher concentrations of ethanol solutions followed by
xylene. Samples were then permeated at 4 °C, resin-embedded at 11
°C (Technovit 9100, Kulzer), and sectioned to produce 6 μm-thick
tissue sections using a Leica RM2255 sawing microtome. Sets of three
sections were cut 150 μm apart and then processed for the following
staining: hematoxylin−eosin, Goldner’s trichrome, and Von Kossa
staining (Atlantic Bone Screen, France). Brieﬂy, for hematoxylin−
eosin staining, sections were immersed in hematoxylin solution and
washed and stained with 10% eosin solution. Sample dehydration with
ethanol and xylene solutions was performed before mounting with
resinous mounting solution. For Goldner’s trichrome staining,
samples were stained with hematoxylin solution followed by
incubation in picric acid solution. After washing, samples were
stained with Fuchsin Ponceau and washed with 1% phosphomolybdic
acid solution. A light green solution was used to stain the samples
before dehydration in ethanol and xylene solutions and then resin
mounting solution was used. For Von Kossa staining, sections were
Figure 1. Properties of the PBG microspheres implanted. (A) Representative SEM images of P40 and P40Ti2.5 microspheres. (B−D) Evaluation
of porosity (B), density (C), and percentage of mass loss (D) for both formulations.
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stained using a 1% silver nitrate solution and exposed to UV light.
Excess staining was removed using a 5% sodium thiosulfate solution
before counterstaining with Fuchsin Ponceau staining. Samples were
dehydrated with ethanol and xylene solutions and mounted using
resin mounting solution.
Quantitative image analysis was performed on Goldner’s trichrome
and Von Kossa stained sections using ImageJ software. Images were
processed through the Feulgen Light Green plugin or the RGB plugin
for Goldner’s trichrome and Von Kossa stained images, respectively,
to separate image color channels. For Goldner’s trichrome staining,
images were generated in pink, green, and orange, while for Von
Kossa staining, images in green, blue, and red were obtained. For
signal quantiﬁcation, all images were converted to grayscale and the
signal threshold was established. For Goldner’s trichrome staining,
green images were used for the quantiﬁcation of a collagen bone-like
matrix, while for the osteoid tissue, pink images were used. For Von
Kossa staining, blue images were used for the evaluation of
mineralized tissue content. In all cases, the calculation was done
over the ROI2 surface (Suppl. Figure 3B) of two replicates per animal.
Imaging. Representative images of hematoxylin−eosin stained
sections were obtained using a Nanozoomer (Nanozoomer 2.0 HT,
Hamamatsu, Hamamatsu, Japan) and visualized using the Nano-
Zoomer Digital Pathology program. For the semiquantitation of
ﬁbrous plug thickness, 4× magniﬁcation images were obtained using
EVOS XL-Core system. Representative images of Goldner’s trichrome
and Von Kossa stained sections were taken using an EclipseT2 Nikon
microscope coupled with a D3300 Nikon camera.
Statistical Analysis. Micro-CT data were analyzed using a one-
way analysis of variance and a post hoc Tukey’s test, while for
histology data analysis, the Kruskal−Wallis nonparametric test was
applied, followed by Dunn’s post hoc test. All statistical analyses were
carried out using the statistical package GraphPad PRISM version
7.03, and all data are shown as mean values ± standard error of the
mean (SEM).
■ RESULTS
Microsphere Characterization. Two formulations of
porous PBG microspheres were prepared in the system
(40P2O5·16CaO·24MgO·(20 − x)NaO·xTiO2 (x = 0, 2.5
mol %)) (Table 1).14 The microsphere diameters ranged
between 100 and 200 μm, while porosity measured 76% ± 4
for P40 and 68% ± 2 for P40Ti2.5 samples (Figure 1A,B). The
average pore diameters of P40 and P40Ti2.5 formulations were
reported to be 55 ± 2 and 38 ± 4 μm, respectively (Suppl.
Figure 2). Interestingly, the pore size distribution curve of the
P40 formulation showed a wide range of values spanning from
nano to micron-scale, whereas the P40Ti2.5 microspheres
displayed pore size mainly in the micron range. Similar values
of bulk and tapped densities were obtained for both
formulations (Figure 1C). The in vitro material degradation
proﬁles analyzed over 30 days in deionized water showed mass
losses of 30 and 5% for P40 and P40Ti2.5, respectively (Figure
1D).
In Vivo Bone Implantation. All animals displayed a good
postoperative recovery, without requiring additional analgesia
beyond day 3 post-surgery; no infections were observed.
Weight and body condition scores were recorded for each
animal before the surgery and at the 13 week end point for the
monitoring of animal wellness during the study. Body weights
of all animals increased an average of 6 ± 7 kg over the 13
week study. All animals, that either received microspheres or
were control animals, had average body condition scores at
sacriﬁce of 3.21 ± 0.33 and 3.44 ± 0.62, respectively, with a
score of 3 classed as a healthy body condition score. This
Figure 2.Micro-CT analysis. (A) Representative micro-CT cross sections of the animal groups treated with porous PBG formulations combined or
not with bone marrow concentrate (BMC), negative empty control, and positive ABG control. Images of established healthy bone and ex vivo
microsphere samples of both formulations were included as reference. White frame deﬁned the defect region. (B−E) Quantiﬁcation of new
mineralized (B, D) and immature bones (C, E) within the defect of the six groups of treatment. Both parameters were measured either in a 9 mm ×
15 mm region of interest (occupying the whole defect) or in a core region of 6 mm × 8 mm. Graphs show mm3 of new tissue. ABG: autologous
bone graft. Dotted lines in the graphs indicate the signal of established healthy bone. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
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suggested that no issues were encountered with the safety of
the procedure and the materials tested.
Evaluation of Bone Formation through Microcom-
puted Tomography. The formation of immature and
mineralized bones was quantiﬁed within all defects through
micro-CT analysis at the 13 week time point. Representative
micro-CT images for all animal groups as well as for both
microsphere formulations scanned ex vivo setting the same
parameters used for the bone samples (255/50 and 255/70)
are shown in Figure 2A. A thick mineralized border was
detected at the edge of the defect for all of the groups that
received materials as well as the empty group. Interestingly, a
strong signal was detected particularly for the P40Ti2.5
formulation (Figure 2A). Evaluation of mineralized bone
over the whole defect showed signiﬁcantly higher values for the
ABG positive control group in comparison to those for all
other groups (p < 0.0001), including the empty negative
control, conﬁrming the eﬀectiveness of the model (Figure 2B).
Despite the lack of mineralization in the central area, high
micro-CT values were obtained for the empty negative control,
which might be due to the pronounced mineralized border
observed (Figure 2A,B). Therefore, the second smaller (6 mm
× 8 mm) core region of interest was considered for all samples
to evaluate the mineralization in the center of the defect and
exclude the defect border (Suppl. Figure 3A). When the
analysis was performed over this region, both groups treated
with P40Ti2.5 showed signiﬁcantly higher values in compar-
ison to the empty negative control (p < 0.01), and a signiﬁcant
diﬀerence was also observed between the P40Ti2.5 and P40
formulations (p < 0.01), while the ABG control presented
signiﬁcantly higher values in comparison to all other treatment
groups (p < 0.0001) (Figure 2C).
The evaluation of immature bone content was also
performed over the same regions of interest (Suppl. Figure
3A). In this case, signiﬁcantly higher values were observed for
both P40Ti2.5 groups (P40Ti2.5 and P40Ti2.5 + BMC) in
comparison to the P40 counterparts (P40Ti2.5 vs P40: p <
0.0001; P40Ti2.5 + BMC vs P40 + BMC: p < 0.001) and the
negative empty control (P40Ti2.5/P40Ti2.5 + BMC vs empty:
p < 0.01) in both the whole defect and core region (Figure
2D,E). Also, while the ABG positive control showed a
signiﬁcantly lower amount of immature bone in comparison
to the P40Ti2.5 groups in the whole defect region, an opposite
trend was observed for the core region, where the signal was
signiﬁcantly higher in comparison to all other groups (p <
0.0001).
Histological Tissue Assessment. All samples were
stained with hematoxylin and eosin for the evaluation of tissue
formation, structure, and organization (Figure 3). The edges
between the defect and the surrounding tissue appeared to be
linear without any signs of osteolysis (Figure 3A). A marked
ﬁbrous plug was present at the top of the defect in both groups
treated with P40 microspheres (P40 and P40 + BMC), while
this was signiﬁcantly thinner in both P40Ti2.5 and P40Ti2.5 +
BMC groups and in the ABG positive control (Figure 3A,D).
While the formation of new connective tissue, stained in pale
pink in H&E staining, was detected in all PBG groups, this was
observed to be denser, more developed, and interconnected in
both P40Ti2.5-treated groups (Figure 3A,C). In these groups,
a certain degree of physical and structural continuity could be
seen between the new tissue and the surrounding endogenous
Figure 3. Hematoxylin and eosin (H&E) staining. Representative nanozoomed images of H&E stained tissue sections of the groups treated with
the porous PBG microspheres (with and without bone marrow concentrate) and the positive ABG control. (A) Representative images at low
magniﬁcation, showing the tissue organization within the entire defect area (deﬁned by a dotted line). Insets numbered as 1 and 2 correspond to
the area shown at higher magniﬁcation in (B) and (C), respectively. Scale bar: 2 mm. (B) Zoomed-in area at the edge between the defect and
endogenous bone. Scale bar: 150 μm. (C) Detail of the organization and tissue structure in the inner area of the defects. Black arrows indicate new
tissue ﬁlling porous microspheres (dotted circles). Scale bar: 50 μm. (D) Semiquantitation of the ﬁbrous plug at the entrance of the defect. (E)
Semiquantitation of the % area within the defect covered by fatty bone marrow tissue. Dotted lines in (D) and (E) indicate the values obtained for
the ABG positive control group. FP: ﬁbrous plug; ABG: established bone graft; fBM: fatty bone marrow. *p < 0.05; ****p < 0.0001.
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tissue, which could be attributed to the presence of the porous
microspheres providing support to the connective tissue and
maintaining contact with the surrounding bone tissue (Figure
3B). Conversely, in P40-treated animals, the connective tissue
resembled organized trabeculae-like structures in addition to
mineralized bone spicules, which were sparse and isolated
without signiﬁcant interaction with the surrounding bone. In
the P40 groups, abundant fatty marrow tissue was observed in
the space between the trabeculae-like growth within the defect,
resulting in signiﬁcantly higher amounts in comparison to the
other groups (p < 0.0001) (Figure 3C,E). It is worth noting
that residual microspheres were visible within the defects
treated with P40Ti2.5, and new connective tissue was seen to
have developed around the microspheres, invading the pore
structure (Figure 3C, black arrows), while in P40-treated
defects, the material was less visible and seemed to have
resorbed.
Evaluation of Bone-like Collagen and Immature
Osteoid Tissue Content. The amount of bone matrix
collagen and osteoid tissue within the defect was assessed
through Goldner’s trichrome staining (Figure 4A). Semi-
quantitation showed that collagen (in green) occupied
between 20 and 40% of the entire defect across all PBG
groups, and signiﬁcantly higher values were observed for the
group treated with P40Ti2.5 in comparison to both P40-
treated groups (p < 0.0001) as well as to P40Ti2.5 + BMC (p
< 0.01) (Figure 4B). Moreover, low-level staining for osteoid
tissue was observed (visible in red) across all formulations
(Figure 4C). Despite the low values detected, signiﬁcantly
higher amounts of osteoid tissue were present in both groups
treated with P40Ti2.5 in comparison to the P40-treated groups
(P40Ti2.5 vs P40: p < 0.001; P40Ti2.5 + BMC vs P40 +
BMC: p < 0.01).
Evaluation of Inﬂammatory Response. The possible
induction of an inﬂammatory response evoked by the
implanted material was also evaluated in Goldner’s trichrome
stained sections (Figure 5). Small lymphoid-like inﬂammatory
cells were observed in two out of four animals in the P40Ti2.5
group and three out of four animals in the P40Ti2.5 + BMC
group, while they were not observed in animals treated with
the P40 formulations or in the ABG positive control (Figure
5A). Within P40Ti2.5-treated groups, numerous multi-
nucleated giant cells (MNGCs) were found in close proximity
Figure 4. Goldner’s trichrome staining and semiquantiﬁcation of collagen and osteoid tissue content. (A) Representative images of tissue sections
stained with Goldner’s Trichrome to evaluate the presence of bone-like collagen (green) and osteoid tissue (red). (B) Semiquantitation of collagen
and osteoid tissue content (C) in the four groups. Dotted lines indicate the values obtained in the positive ABG group. Graphs show the % over the
total surface of soft tissue within the defect (ROI2). ABG: autologous bone graft. Scale bar: 125 μm **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 5. Images of inﬂammatory cells within the defect of P40Ti-
and P40Ti2.5-treated groups. (A) Representative images of
inﬂammatory lymphoid cells within the defect of the groups treated
with both P40Ti2.5 formulations. (B) Multinucleated cells (arrows)
were also observed in proximity of nondegraded microsphere residue
(asterisk). Scale bar: 125 μm.
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to nondegraded microspheres (Figure 5B, arrows and stars,
respectively).
Evaluation of Mineralized Bone Fill. Von Kossa staining
was performed to evaluate the content of mineralized bone
(stained in black) (Figure 6A). Both groups that were treated
with P40 microspheres, with or without BMC, presented large
and deﬁned black-stained areas within the trabeculae-like
structures observed in the defect. Conversely, a diﬀerent
staining pattern was observed for the P40Ti2.5 and P40Ti2.5 +
BMC groups, where the positive black signal was limited to the
residual nondegraded microspheres (Figure 6A and Suppl.
Figure 4). Semiquantitation of the mineralized tissue fraction
over the total surface of the defect conﬁrmed these
observations with higher values for both groups treated with
P40 (Figure 6B), although only the diﬀerence between P40 +
BMC and P40Ti2.5 + BMC groups reached statistical
signiﬁcance (p < 0.05).
■ DISCUSSION
This study describes the biocompatibility and osteogenic
response to two quaternary formulations of phosphate-based
glass (PBG) from the system 40P2O5·16CaO·24MgO·(20 −
x)NaO·xTiO2 (x = 0, 2.5 mol %) (Table 1) manufactured as
novel porous microspheres utilizing a single-step manufactur-
ing process. As shown recently, the porous P40 microspheres
supported in vitro cell growth, adhesion, and colonization of
the pores using an immortalized line of hMSCs.14 In line with
this observation, newly formed connective tissue was observed
in this study within the pores of microspheres after 13 weeks.
This new tissue was observed to grow within a three-
dimensional construct. This is consistent with studies where
porous materials have been considered superior for tissue
regeneration in comparison to their nonporous counterpart
due to enhanced tissue ingrowth and inﬁltration and
vascularization.22,23 Several studies have attempted to deﬁne
the inﬂuence of material pore size on the outcome of new bone
formation in vivo, with contrasting results. For instance, when
comparing ceramic scaﬀolds with diﬀerent pore sizes between
50 and 500 μm, larger values were associated with more bone
formation.24−26 However, an opposite trend has been reported
in a recent study by Diao and colleagues, with 100 μm pore
scaﬀolds performing better than 250 and 400 μm pore
devices.27 In this study, the Ti-free P40 formulation presented
slightly larger pores than the P40Ti2.5, which could be due to
the higher glass density for the latter. As previously shown, the
range of pore size obtained (30−50 μm) is suitable to promote
cell migration and colonization.14
The addition of small quantities of TiO2 to the glass
formulation is a known strategy for the control of PBG
degradation rates.9,12 In our study, the decreased degradation
rate (only 5% degradation was observed after 30 days for
P40Ti as opposed to 30% for P40) was associated with delayed
resorption of the P40Ti2.5 microspheres, which were still
visible after 13 weeks, while the P40 microspheres appeared
fully resorbed. These observations are in agreement with
previous reports that the timing of material degradation can
signiﬁcantly inﬂuence the outcome of the therapeutic
approach.28,29
The histological analysis revealed marked diﬀerences
between defects treated with Ti-free and Ti-containing porous
PBG microspheres. The ﬁrst visible diﬀerence induced by the
two formulations was the density of the connective tissue
within the defects, which was visibly higher in the P40Ti2.5-
treated groups. This tissue detected in P40Ti2.5-treated groups
also appeared to have a diﬀerent structure in comparison to
that in P40-treated ones. Despite the trabeculae-like
architecture visible in P40-treated groups, these presented
low or no interconnection with each other or with the
surrounding bone tissue. In the P40Ti groups, the connective
tissue was widely distributed around and inside the residual
nondegraded microspheres with no trabecular-like organiza-
tion, which suggested that the long-term presence of
nondegraded materials, beyond stimulating more tissue
formation, may have delayed the tissue maturation and bone
Figure 6. Von Kossa staining and quantiﬁcation. (A) Representative images of tissue sections stained with Von Kossa for the detection of
mineralized tissue (black) in the four groups. (B) Semiquantitation of mineralized tissue indicated as % over the total surface of the entire defect
(ROI2). Dotted line indicates the value obtained in the positive ABG control. Scale bar: 125 μm. ABG: autologous bone graft. *p < 0.05.
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remodeling process.30 The formation of trabeculae is essential
for the correct bone functionality. Parameters such as
trabecular number, trabecular separation, and distribution
have been associated with higher incidence of fractures in a
cohort of female individuals aﬀected by osteoporosis, while a
speciﬁc intertrabecular angle characterizes healthy bone,
highlighting the importance of the correct structural tissue
organization.31,32
In addition to the diﬀerent amounts of connective tissue
induced by the two formulations tested in this study at 13
weeks, they also induced diﬀerent levels of mineralization in
the respective treatment groups, with a higher amount of
mineralized tissue detected in groups treated with the P40
formulation. PBGs represent instructive materials as the ions
released during the degradation process may act as
determinants of biological processes, with the ability to
inﬂuence stem cell diﬀerentiation and promote mineralization.
In particular, the principal ions released by the materials tested
in this study (calcium, magnesium, sodium, and phosphate)
have been described to exert inﬂuential eﬀects on osteoblast
cells, including the induction of proliferation and mineraliza-
tion.9,33,34 Studies also indicated that not only the type of ions
released but also the relative amounts released from the
material are critical for tissue regeneration.35 Based on these
considerations, it is reasonable to consider that the diﬀerent
degradation rates characterizing the two formulations studied
here aﬀected tissue formation through both an instructive and
a structural eﬀect. It would now be useful to analyze the in situ
eﬀect of the material degradation on speciﬁc lineages, including
osteoblasts and osteoclasts, to fully characterize the nature of
the tissue response.
Results of the mineralized bone content obtained through
Von Kossa staining appeared to partially contradict the results
provided by the micro-CT analysis, which initially showed
signiﬁcantly higher values for both the P40Ti2.5 groups.
However, the strong signal observed from the ex vivo scan for
both microsphere formulations suggested that the micro-CT
values might be overestimating the new mineralized bone
because of the high intrinsic signal from the P40Ti2.5 material
itself, which could be due to the Ti incorporated within the
formulation.36,37 It would thus be of interest to consider
extending the follow-up period (6−12 months) so that the
long-term eﬀect of the formulations on defect mineralization
could be untangled from the presence of the remaining
material.
Another marked diﬀerence between the two formulations
highlighted by the histological analysis was the presence of
lymphoid-like inﬂammatory cells within the defects in
P40Ti2.5-treated tissues.38 As part of the adaptive immunity,
these cells play a role in wound healing and body response to
biomaterials and foreign bodies.39 Beyond the morphological
identiﬁcation, a cell marker analysis for the speciﬁc lineages
(e.g., Th1 and Th2 lymphocytes) present in the tissue could
provide further information on the possible pro- or anti-
inﬂammatory nature of such a response, as these cells are
known to produce diﬀerent panels of cytokines.40,41 Moreover,
cells resembling multinucleated giant cells (MNGCs) were
observed in direct contact with nondegraded materials, which
were more prominent in the Ti-treated groups, as expected
from their slower degradation rate. These foreign body
MNGCs have intrinsic phagocytic activity and could be
involved in the physical elimination of the residual materials
from the defect.42 Evidence from in vitro studies suggested that
the physical properties of the materials, including particle size
and material composition, may stimulate such a phagocytic
activity. Milde and colleagues observed that larger particles
exerted an inductive eﬀect on these cells, while the addition of
calcium phosphate glass containing 5 mol % of TiO2 to a
polymeric scaﬀold, which reduced its degradation rate together
with high surface erosion and debris release, was reported to
stimulate a signiﬁcantly higher number of foreign body
MNGCs than the glass-free counterpart, in line with the
observations made in this study.43,44 Further analysis using
speciﬁc immunological markers would help to fully character-
ize cell types and understand their role in the body response to
the implanted materials. Barbeck and co-workers observed the
expression of the integrin-beta2 receptor in foreign body
MNGC phagocytic cells in the presence of a HA-based
synthetic material (NanoBone) but not in osteoclast-like cells
in contact with bone matrix.42 The detection of osteoclasts
using TRAP staining, which was not possible here due to the
sample-processing procedure, could also allow the assessment
of resorption activity in the treated defects. It is important to
highlight that beyond the inﬂammatory cellular inﬁltrate
observed within the defects, this local reaction did not appear
to aﬀect animal behavior, body score, and weight over the
study period, which indicated the general safety of the surgical
approach and the biocompatibility of the materials tested.
Our results also indicate that the addition of bone marrow
concentrate (BMC) did not appear to yield any signiﬁcant
additional beneﬁcial eﬀect for the parameters analyzed. This
was unexpected since the use of autologous BMC is largely
accepted as an advantageous cell therapy strategy for diﬀerent
applications, including bone healing, due to the expected
enrichment in mesenchymal precursors with osteogenic
potential among other progenitors present.16,17 The absence
of signiﬁcant beneﬁt for BMC in the present study could be
due to a suboptimal amount of stem cells introduced to the
defects, or to the insuﬃcient engraftment of the cells after
delivery to the defect. A prospective clinical trial performed in
2011 showed the ability of BMC to promote complete bone
healing in bone defects of ≥1 cm × 1 cm when combined with
either a hydroxyapatite scaﬀold or with a collagen sponge.45 In
this study, the authors performed a 15 min incubation to allow
the cells to adhere to the carrier material; in this way, the
dispersion of the cells once implanted in vivo could be
prevented, possibly increasing the retention of the implanted
cells in situ and therefore their eﬃcacy.
Beside the bioactivity and the osteointegration shown in this
study, these porous microspheres are characterized by low
mechanical strength making them compactable and thus
particularly suitable for defect ﬁlling. These features are shared
with other materials largely used in the clinic, including
hydroxyapatite (HA), β-tricalcium phosphate (β-TCP), and
silicate-based bioglasses. HA shows good osteoconductivity
and biocompatibility; however, it is poorly resorbable (5.4%
after 6 months), aﬀecting the quality and mechanical strength
of the new tissue.46 β-TCP is regarded as being more
degradable than HA, resembles the structure and mechanical
properties of cancellous bone, and may take up to 24 months
to fully resorb.47 It is mainly used in the clinic as a bone defect
ﬁller.48,49 The silicate-based bioglasses (such as 45S5, 13−93,
and S53P4) are also available on the market for bone
regeneration, showing good compatibility and integration
with the host tissue.50 A study comparing the regenerative
ability of bioglasses 45S5, HA, and β-TCP in a goat radius
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bone defect showed superior regenerative results, including
higher bone growth rate and osteointegration, for the 45S5
bioglass scaﬀold in comparison to HA and β-TCP,3 high-
lighting the importance of ion release and material bioactivity.
From these materials already used in the clinic, the porous
PBG microspheres presented in this study provide signiﬁcant
advantage of being highly tailorable in both geometry,
formulation, and hence degradation proﬁles. In addition,
their controllable bioresorbability is a highly desired property
for tissue engineering application, as it can be progressively
substituted by native tissue restoring physiological function-
ality. It would also prevent the complications related to the
long-term presence of foreign bodies in the organism.51 As
such, these highly porous PBG microsphere biomaterials
constitute a promising alternative to the existing materials for
bone tissue engineering application.
In summary, this study utilizing a sheep knee bone defect
model showed that porous phosphate-based glass microspheres
are good candidates for tissue regeneration application in vivo,
as they are biocompatible and promoted new bone tissue
formation and osteointegration. For these properties, they
indeed constitute a valid alternative to the use of bone graft for
bone regeneration, although this is still considered the golden
standard, showing a more powerful performance in terms of
the amount and quality of new bone formed due to their
natural and biomimetic features. Bone grafts are indeed rich in
many of those growth factors known to be key in tissue
regeneration, including BMP-2, BMP-4, FGF, PDGF, and IGF-
1 among others, but also to provide the optimal structural
support through the ECM network to promote not only new
tissue formation and maturation but also vascularization and
host tissue integration resulting in very high quality out-
comes.52,53 Considering these results, alternate formulations
with an intermediate degradation rate tailored to more closely
match the kinetics of bone regeneration and remodeling
processes would represent an excellent strategy to achieve
higher amounts of mineralized tissue with signiﬁcantly more
developed trabecular organization. A follow-up study with a
longer end point beyond the 13 week period analyzed here
would also be useful to allow slower degrading formulations to
fully resorb and provide better support for completion of the
remodeling process.
■ CONCLUSIONS
This study evaluated the biological potential of two PBG
formulations, with or without titanium, manufactured as
porous microspheres suitable for injection in minimally
invasive procedures. Both materials were observed to be
biocompatible, and their diﬀerent degradation rates were
associated with a clearly diﬀerent tissue response, conﬁrming
the importance of this parameter among others in the design of
new biomaterials. From the two formulations tested, the faster
degrading P40 formulation produced poor trabecular-like
interconnection, which may negatively aﬀect tissue function-
ality. Conversely, the slow degrading P40Ti2.5 microspheres,
which were still visible within the host tissue at the 13 week
end point, promoted dense interconnected tissue but also
delayed tissue maturation and remodeling. Therefore, the
development of a formulation with an intermediate degrada-
tion proﬁle could provide a valuable strategy to further
improve the tissue regenerative response to the material and its
potential for bone repair.
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